annual SGA:
$63.53M+$8.49M(+15.43%)Summary
- As of today (July 1, 2025), KYMR annual SGA is $63.53 million, with the most recent change of +$8.49 million (+15.43%) on December 31, 2024.
- During the last 3 years, KYMR annual SGA has risen by +$27.19 million (+74.81%).
- KYMR annual SGA is now at all-time high.
Performance
KYMR SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$16.27M-$61.00K(-0.37%)Summary
- As of today (July 1, 2025), KYMR quarterly SGA is $16.27 million, with the most recent change of -$61.00 thousand (-0.37%) on March 31, 2025.
- Over the past year, KYMR quarterly SGA has increased by +$1.90 million (+13.20%).
- KYMR quarterly SGA is now -6.34% below its all-time high of $17.37 million, reached on June 30, 2024.
Performance
KYMR quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$2.88B-$240.88M(-9.13%)Summary
- As of today (July 1, 2025), KYMR TTM SGA is -$2.88 billion, with the most recent change of -$240.88 million (-9.13%) on March 31, 2025.
- Over the past year, KYMR TTM SGA has dropped by -$2.94 billion (-5166.02%).
- KYMR TTM SGA is now -3666.91% below its all-time high of -$76.46 million.
Performance
KYMR TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
KYMR Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.4% | +13.2% | -5166.0% |
| 3 y3 years | +74.8% | +53.3% | -7116.4% |
| 5 y5 years | +696.1% | +535.8% | -10000.0% |
KYMR Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +74.8% | -6.3% | +54.1% | -189.3% | at low |
| 5 y | 5-year | at high | +696.1% | -6.3% | +344.4% | -1460.6% | at low |
| alltime | all time | at high | +1584.4% | -6.3% | +984.0% | -3666.9% | at low |
KYMR Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $16.27M(-0.4%) | $65.43M(+3.0%) |
| Dec 2024 | $63.53M(+15.4%) | $16.33M(+5.7%) | $63.53M(+3.4%) |
| Sep 2024 | - | $15.46M(-11.0%) | $61.43M(+2.2%) |
| Jun 2024 | - | $17.37M(+20.9%) | $60.09M(+5.7%) |
| Mar 2024 | - | $14.37M(+1.0%) | $56.85M(+3.3%) |
| Dec 2023 | $55.04M(+25.6%) | $14.23M(+0.8%) | $55.04M(+4.9%) |
| Sep 2023 | - | $14.12M(-0.1%) | $52.45M(+7.3%) |
| Jun 2023 | - | $14.13M(+12.4%) | $48.89M(+6.8%) |
| Mar 2023 | - | $12.56M(+8.0%) | $45.79M(+4.5%) |
| Dec 2022 | $43.83M | $11.64M(+10.2%) | $43.83M(-0.2%) |
| Sep 2022 | - | $10.56M(-4.3%) | $43.94M(-0.3%) |
| Jun 2022 | - | $11.03M(+4.0%) | $44.05M(+7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $10.61M(-9.6%) | $41.05M(+12.9%) |
| Dec 2021 | $36.34M(+99.3%) | $11.74M(+10.1%) | $36.34M(+22.0%) |
| Sep 2021 | - | $10.67M(+32.9%) | $29.78M(+14.8%) |
| Jun 2021 | - | $8.03M(+35.9%) | $25.95M(+20.2%) |
| Mar 2021 | - | $5.91M(+14.2%) | $21.58M(+18.4%) |
| Dec 2020 | $18.23M(+128.5%) | $5.17M(-24.3%) | $18.23M(+17.0%) |
| Sep 2020 | - | $6.84M(+86.8%) | $15.59M(+52.1%) |
| Jun 2020 | - | $3.66M(+43.1%) | $10.25M(+55.6%) |
| Mar 2020 | - | $2.56M(+1.1%) | $6.59M(+63.5%) |
| Dec 2019 | $7.98M(+111.6%) | $2.53M(+68.6%) | $4.03M(+168.6%) |
| Sep 2019 | - | $1.50M | $1.50M |
| Dec 2018 | $3.77M | - | - |
FAQ
- What is Kymera Therapeutics annual SGA?
- What is the all time high annual SGA for Kymera Therapeutics?
- What is Kymera Therapeutics annual SGA year-on-year change?
- What is Kymera Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly SGA year-on-year change?
- What is Kymera Therapeutics TTM SGA?
- What is the all time high TTM SGA for Kymera Therapeutics?
- What is Kymera Therapeutics TTM SGA year-on-year change?
What is Kymera Therapeutics annual SGA?
The current annual SGA of KYMR is $63.53M
What is the all time high annual SGA for Kymera Therapeutics?
Kymera Therapeutics all-time high annual SGA is $63.53M
What is Kymera Therapeutics annual SGA year-on-year change?
Over the past year, KYMR annual SGA has changed by +$8.49M (+15.43%)
What is Kymera Therapeutics quarterly SGA?
The current quarterly SGA of KYMR is $16.27M
What is the all time high quarterly SGA for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly SGA is $17.37M
What is Kymera Therapeutics quarterly SGA year-on-year change?
Over the past year, KYMR quarterly SGA has changed by +$1.90M (+13.20%)
What is Kymera Therapeutics TTM SGA?
The current TTM SGA of KYMR is -$2.88B
What is the all time high TTM SGA for Kymera Therapeutics?
Kymera Therapeutics all-time high TTM SGA is -$76.46M
What is Kymera Therapeutics TTM SGA year-on-year change?
Over the past year, KYMR TTM SGA has changed by -$2.94B (-5166.02%)